Portal de Periódicos da CAPES

Liver transplantation in patients with hepatic iron overload: Favorable or unfavorable outcome?

2000; Lippincott Williams & Wilkins; Volume: 32; Issue: 6 Linguagem: Inglês

10.1053/jhep.2000.20674

1527-3350

Emmet B. Keeffe,

Trace Elements in Health

HepatologyVolume 32, Issue 6 p. 1396-1398 EditorialFree Access Liver transplantation in patients with hepatic iron overload: Favorable or unfavorable outcome? Emmet B. Keeffe MD, Corresponding Author Emmet B. Keeffe MD [email protected] Stanford University Medical Center, Stanford, CAStanford University Medical Center, 750 Welch Road, Suite 210, Palo Alto, CA 94304-1509. fax: 650-498-5692===Search for more papers by this author Emmet B. Keeffe MD, Corresponding Author Emmet B. Keeffe MD [email protected] Stanford University Medical Center, Stanford, CAStanford University Medical Center, 750 Welch Road, Suite 210, Palo Alto, CA 94304-1509. fax: 650-498-5692===Search for more papers by this author First published: 30 December 2003 https://doi.org/10.1053/jhep.2000.20674Citations: 7AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999; 116: 193–207.MEDLINE 10.1016/S0016-5085(99)70244-1 CASPubMedGoogle Scholar 2 Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med 1998; 129: 925–931.MEDLINE 10.7326/0003-4819-129-11_Part_2-199812011-00002 CASPubMedWeb of Science®Google Scholar 3 Cotler SJ, Bronner MP, Press RD, Carlson TH, Perkins JD, Emond MJ, Kowdley KV. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol 1998; 29: 257–262.MEDLINE 10.1016/S0168-8278(98)80011-1 CASPubMedWeb of Science®Google Scholar 4 Fiel MI, Schiano TD, Bodenheimer HC, Thung SN, King TW, Varma CR, Miller CM, et al. Hereditary hemochromatosis in liver transplantation. Liver Transpl Surg 1999; 5: 50–60.MEDLINE 10.1002/lt.500050109 CASPubMedWeb of Science®Google Scholar 5 Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399–408.MEDLINE 10.1038/ng0896-399 CASPubMedWeb of Science®Google Scholar 6 Bodmer JG, Parham P, Albert ED, Marsh SG. Putting a hold on "HLA-H." The WHO Nomenclature Committee for Factors of the HLA System. Nat Genet 1997; 15: 234–235.MEDLINE 10.1038/ng0397-234c CASPubMedWeb of Science®Google Scholar 7 Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313: 1256–1262.MEDLINE 10.1056/NEJM198511143132004 PubMedWeb of Science®Google Scholar 8 Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzani AL, Fraquelli M, Bianchi PA, et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992; 15: 655–659.MEDLINE 10.1002/hep.1840150417 CASPubMedWeb of Science®Google Scholar 9 Deugnier Y, Turlin B, le Quilleuc D, Moirand R, Loreal O, Messer M, Meunier B, et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am J Surg Path 1997; 21: 669–675.MEDLINE 10.1097/00000478-199706000-00007 CASPubMedWeb of Science®Google Scholar 10 Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997; 112: 882–888.MEDLINE 10.1053/gast.1997.v112.pm9041250 CASPubMedWeb of Science®Google Scholar 11 Brandhagen DJ, Alvarez W, Therneau TM, Kruckeberg KE, Thibodeau SN, Ludwig J, Porayko MK. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation. Hepatology 2000; 31: 456–460.MEDLINE 10.1002/hep.510310227 CASPubMedWeb of Science®Google Scholar 12 Alanen KW, Chakrabarti S, Rawlins JJ, Howson W, Jeffrey G, Adams PC. Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors. Hepatology 1999; 30: 665–669.MEDLINE 10.1002/hep.510300308 CASPubMedWeb of Science®Google Scholar 13 Kowdley KV, Tung BY, Han S, Bass NM, Gish RG, Brandhagen DJ, Sterling R, et al. Prevalence of hepatic iron overload and HFE mutations among orthotopic liver transplant recipients: preliminary results from the National Hemochromatosis Transplant Registry (Abstract). Hepatology 2000; 32: 248A. Web of Science®Google Scholar 14 Kilpe VE, Krakauer H, Wren R. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare. Transplantation 1993; 56: 554–561.MEDLINE 10.1097/00007890-199309000-00012 CASPubMedWeb of Science®Google Scholar 15 Fagiuoli S, Hassanein T, Guraker A, Caraceni P, Wright HI, Tabasco-Miguillan J, Gavaler JS, et al. Liver transplantation for hereditary hemochromatosis (HHC) (Abstract). Gastroenterology 1993; 104: A898. Web of Science®Google Scholar 16 Farrell FJ, Nguyen M, Woodley S, Imperial JC, Garcia-Kennedy R, Man KM, Esquivel CO, et al. Outcome of liver transplantation in patients with hemochromatosis. Hepatology 1994; 20: 404–410.MEDLINE 10.1002/hep.1840200221 CASPubMedWeb of Science®Google Scholar 17 Pillay P, Tzoracoleftherakis E, Tzakis AG, Kakizoe S, Van Thiel DH, Starzl TE. Orthotopic liver transplantation for hemochromatosis. Transplant Proc 1991; 23: 1888–1889.MEDLINE CASPubMedWeb of Science®Google Scholar 18 Kowdley KV, Hassanein T, Kaur S, Farrell FJ, Van Thiel DH, Keeffe EB, Sorrell MF, et al. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transpl Surg 1995; 1: 237–241.MEDLINE 10.1002/lt.500010408 CASPubMedGoogle Scholar 19 Tung BY, Farrell FJ, McCashland TM, Gish RG, Bacon BR, Keeffe EB, et al. Long-term follow-up after liver transplantation in patients with hepatic iron overload. Liver Transpl Surg 1999; 5: 369–374.MEDLINE 10.1002/lt.500050503 CASPubMedWeb of Science®Google Scholar 20 Kowdley KV, Brandhagen DJ, Crippin JS, Gish RG, Bacon BR, Keeffe EB, Sterling R, et al. Survival after orthotopic liver transplantation among patients with hepatic iron overload: preliminary results from the National Hemochromatosis Transplant Registry (Abstract). Hepatology 2000; 32: 228A. Web of Science®Google Scholar 21 Stuart KA, Fletcher LM, Clouston AD, Lynch SV, Purdie DM, Kerlin P, Crawford DH. Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation. Hepatology 2000; 32: 1200–1207.MEDLINE 10.1053/jhep.2000.20348 CASPubMedWeb of Science®Google Scholar Citing Literature Volume32, Issue6December 2000Pages 1396-1398 ReferencesRelatedInformation